Billionaire Ray Dalio's Former Hedge Fund Is Buying These 3 Top Dividend Stocks. Should You?
Billionaire Ray Dalio's former hedge fund has recently invested in three top dividend stocks. ExxonMobil, Medtronic, and Microsoft all offer attractive dividend profiles.
Medtronic chairman and CEO Geoff Martha to speak at the Wells Fargo Healthcare Conference
GALWAY, Ireland , Aug. 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 2024 Wells Fargo Healthcare Conference...
Medtronic: Is The Company Back?
Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic remain...
Federated Hermes achieves shareholder approval related to the Federated Hermes MDT Large Cap Growth ETF
PITTSBURGH , Aug. 23, 2024 /PRNewswire/ -- Federated Hermes, Inc. (NYSE: FHI), a global leader in active investing, today announced that the Federated Hermes ETF Trust, on behalf of its portfolio, ...
What's Next For Medtronic Stock After An Upbeat Q1?
Medtronic (NYSE: MDT) recently reported its Q1 fiscal 2025 results (fiscal ends in April), with revenues and earnings exceeding our estimates. The company reported revenue of $7.9 billion and adjus...
Compared to Estimates, Medtronic (MDT) Q1 Earnings: A Look at Key Metrics (Revised)
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended July 2024, it might be worth considering how some key metrics compare with Wall Stre...
Medtronic CEO: Strong single-digit earnings ahead as forex impact fades in the second half
Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, where the company's business is toughest, and much more.
Medtronic (MDT) Q1 Earnings Beat, Fiscal 2025 View Narrowed
Medtronic (MDT) reports broad-based growth across all major segments, with strong gains in Cardiac Rhythm & Heart Failure, Structural Heart & Aortic, Cranial & Spinal Technologies and Diabetes busi...
Demand for Medtronic's Medical Devices Lifts Profit and Sales
Medtronic (MDT) shares advanced in intraday trading Tuesday as the medical technology firm posted better-than-expected results and raised its guidance on strong demand for its medical devices.
Medtronic reports first quarter fiscal 2025 financial results
Product innovation driving growth across diversified health tech portfolio, including Automated Insulin Delivery, Transcatheter Aortic Valve Replacement, Pulsed Field Cardiac Ablation, Pain Stimula...
Medtronic: Healthy Vital Signs Heading Into Earnings
Medtronic stock underperformed the market, up only 4% in the past year. The options market predicts a 3.3% stock price swing post-earnings. Mid-single-digit EPS growth, rising dividends, and histor...
Medtronic: Still A Buy Before Earnings
Medtronic is a strong option for investors seeking both low volatility and consistent dividend growth. I am quite positive about recent developments related to new crucial FDA approvals. Various va...
Calls of the Day: Medtronic, Boeing, Uber, Oracle and Las Vegas Sands
The Investment Committee debate the latest Calls Of The Day
Medtronic (MDT) Increases Yet Falls Behind Market: What Investors Need to Know
In the closing of the recent trading day, Medtronic (MDT) stood at $82.27, denoting a +1.33% change from the preceding trading day.
Medtronic to announce financial results for its first quarter of fiscal year 2025
GALWAY, Ireland , Aug. 12, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its first quarter of fi...
Related Companies